tert-Butyl 4-(6-acetamido-5-methylpyridin-3-yl)piperidine-1-carboxylate

Catalog No. :
ACNJEB245
CAS No. :
1820614-58-1
Molecular Formula :
C18H27N3O3
Molecular Weight :
333.43

IUPAC Name:tert-butyl 4-(6-acetamido-5-methylpyridin-3-yl)piperidine-1-carboxylate

tert-Butyl 4-(6-acetamido-5-methylpyridin-3-yl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$195.00Login to see priceInquiryInquiry
250mg97%$312.00Login to see priceInquiryInquiry
1g97%$702.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(6-acetamido-5-methylpyridin-3-yl)piperidine-1-carboxylate
IUPAC Nametert-butyl 4-(6-acetamido-5-methylpyridin-3-yl)piperidine-1-carboxylate
MDL No.MFCD28166406
Molecular FormulaC18H27N3O3
Molecular Weight333.43
SMILESO=C(N1CCC(C2=CC(C)=C(NC(C)=O)N=C2)CC1)OC(C)(C)C
InChI KeyAMZXZGQMLWYFRU-UHFFFAOYSA-N
Synonymtert-Butyl 4-(6-acetamido-5-methylpyridin-3-yl)piperidine-1-carboxylate;1-Piperidinecarboxylic acid, 4-[6-(acetylamino)-5-methyl-3-pyridinyl]-, 1,1-dimethylethyl ester
CAS No.1820614-58-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNJEB245 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNJEB245 route product structure diagram
    ACNJEB2451820614-58-1
Inquiry

2. ACNJEB245 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNJEB245 route product structure diagram
    ACNJEB2451820614-58-1
Inquiry

Comments (0)